What's breaking now, across thousands of outlets.
Beam Therapeutics on Tuesday shared additional data from an early-stage trial of its gene therapy candidate in a rare disease that causes lung and liver damage. In six patients in a Phase 1/2 study, a ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Rural health systems are seeking partnership to survive, fueling a debate over competition and the rising cost of medical care.
“As a medical student in a larger body, I have often been ostracized, othered, made to feel different, like I’ve invaded a secret society of thin people.”
Most of the time, it’s unnecessary to use gloves to administer a flu shot, write Cassandra Thiel and Preeti Jaggi.
Good rehabilitation starts with a simple question: “What do you want to get back to?” The answer may be different for every person. And that answer becomes an important part of the treatment
Four Costa Blanca communities are coming together this September for a charity walk supporting people living with Alzheimer’s and the […]
Clinical trials confirmed base editing therapy achieved total transfusion independence in beta thalassemia patients while delivering durable clinical remission across diverse genetic backgrounds
